Skip to content

Influence of Central Sensitization on Efficacy of Patient-controlled Epidural Analgesia in Osteoarthritis Patients Undergoing Total Knee Replacement

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01863342
Enrollment
98
Registered
2013-05-27
Start date
2013-05-31
Completion date
2014-05-31
Last updated
2013-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

central sensitization; osteoarthritis; epidural analgesia

Brief summary

Nociceptor inputs can trigger a prolonged but reversible increase in the excitability and synaptic efficacy of neurons in central nociceptive pathways, the phenomenon of central sensitization. The degenerative joint disease, osteoarthritis, with characteristic destruction of cartilage and alteration in bone is a very common cause of chronic pain. The degree of pain does not always correlate with the extent of joint damage or presence of active inflammation raising the possibility that there may be a central component to the pain. The central sensitization inventory (CSI) is a new self-report screening instrument to measure the degree of central sensitization, and to help identify patients with central sensitivity syndromes. The aim of this investigation is to evaluate the influence of preoperative central sensitization, which represented by CSI score, on postoperative pain score in osteoarthritis patients undergoing total knee replacement who receiving patient-controlled epidural analgesia.

Interventions

PROCEDURECSI score < 40
PROCEDURECSI score ≥ 40

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Aged 20 to 80 years osteoarthritis patients undergoing total knee replacement under spinal anesthesia, and who receiving postoperative epidural PCA

Exclusion criteria

* refusal * coagulopathy * neurologic deficit * preoperative opioids medication * recent analgesics change

Design outcomes

Primary

MeasureTime frameDescription
Peak pain scoreat the point of Epidural PCA to postoperative 1-48 hNumeric rating scale (0 to 10 points) at each assessment interval

Countries

South Korea

Contacts

Primary ContactShin Hyung Kim, MD
tessar@yuhs.ac82-2-2227-3556

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026